Association Between Programmed Death-Ligand 1 Expression and Clinicopathological Characteristics, Structural Recurrence, and Biochemical Recurrence/Persistent Disease in Medullary Thyroid Carcinoma

Shi, X; Yu, PC; Lei, BW; Li, CW; Zhang, Y; Tan, LC; Shi, RL; Wang, J; Ma, B; Xu, WB; Wang, X; Hu, JQ; Huang, NS; Wei, WJ; Wang, Y; Chen, TZ; Wang, YL; Ji, QH

Wang, YL; Ji, QH (reprint author), Fudan Univ, Shanghai Canc Ctr, Dept Head & Neck Surg, 270 Dong An Rd, Shanghai 200032, Peoples R China.; Chen, TZ (reprint author), Fudan Univ, Shanghai Canc Ctr, Dept Pathol, 270 Dong An Rd, Shanghai 200032, Peoples R C

THYROID, 2019; 29 (9): 1269

Abstract

Background: Expression of the programmed death-ligand 1 (PD-L1) in medullary thyroid carcinoma (MTC) has been rarely reported. In this study, we evalu......

Full Text Link